Cargando…

A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome

PTEN hamartoma tumor syndrome (PHTS) is a complex neurodevelopmental disorder characterized by mechanistic target of rapamycin (mTOR) overactivity. Limited data suggest that mTOR inhibitors may be therapeutic. No placebo-controlled studies have examined mTOR inhibition on cognition and behavior in h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, Siddharth, Jo, Booil, Zhang, Bo, Frazier, Thomas, Gallagher, Anne Snow, Peck, Fleming, Levin, April R, Mondal, Sangeeta, Li, Zetan, Filip-Dhima, Rajna, Geisel, Gregory, Dies, Kira A, Diplock, Amelia, Eng, Charis, Hanna, Rabi, Sahin, Mustafa, Hardan, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558845/ https://www.ncbi.nlm.nih.gov/pubmed/35594551 http://dx.doi.org/10.1093/hmg/ddac111

Ejemplares similares

A randomized double-blind controlled trial of everolimus in individuals with PTEN mutations: Study design and statistical considerations
por: Hardan, Antonio Y., et al.
Publicado: (2021)

Longitudinal neurobehavioral profiles in children and young adults with PTEN hamartoma tumor syndrome and reliable methods for assessing neurobehavioral change
por: Busch, Robyn M., et al.
Publicado: (2023)

The microbiome in PTEN hamartoma tumor syndrome
por: Byrd, Victoria, et al.
Publicado: (2017)

The mitochondrial genome as a modifier of autism versus cancer phenotypes in PTEN hamartoma tumor syndrome
por: Wei, Ruipeng, et al.
Publicado: (2023)

Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN
por: Busch, Robyn M., et al.
Publicado: (2019)

Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome
por: Brewer, Takae, et al.
Publicado: (2023)

Psychiatric Characteristics Across Individuals With PTEN Mutations
por: Steele, Morgan, et al.
Publicado: (2021)

Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
por: Krueger, Darcy A., et al.
Publicado: (2017)

PTEN Hamartoma Tumor Syndrome and Immune Dysregulation()()()
por: Eissing, Marc, et al.
Publicado: (2018)

Hamartoma-like lesions in the mouse retina: an animal model of Pten hamartoma tumour syndrome
por: Tachibana, Nobuhiko, et al.
Publicado: (2018)

Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism
por: Frazier, Thomas W., et al.
Publicado: (2021)

PTEN Hamartoma Tumor Syndrome: A Clinical Overview
por: Pilarski, Robert
Publicado: (2019)

Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells
por: Chen, Hannah H., et al.
Publicado: (2017)

Molecular and Phenotypic Abnormalities in Individuals with Germline Heterozygous PTEN Mutations and Autism
por: Frazier, Thomas W., et al.
Publicado: (2014)

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome
por: Tischkowitz, Marc, et al.
Publicado: (2020)

Thyroid pathology, a clue to PTEN hamartoma tumor syndrome
por: Lee, Yurimi, et al.
Publicado: (2023)

Distinct metabolic profiles associated with autism spectrum disorder versus cancer in individuals with germline PTEN mutations
por: Yehia, Lamis, et al.
Publicado: (2022)

Gingival Overgrowths Revealing PTEN Hamartoma Tumor Syndrome: Report of Novel PTEN Pathogenic Variants
por: Sutera, Samuele, et al.
Publicado: (2022)

PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis
por: Innella, Giovanni, et al.
Publicado: (2021)

Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations
por: Yehia, Lamis, et al.
Publicado: (2020)

“Thyroid nodular disease and PTEN mutation in a multicentre series of children with PTEN hamartoma tumor syndrome (PHTS)”
por: Tuli, Gerdi, et al.
Publicado: (2021)

Using the big data approach to clarify the structure of restricted and repetitive behaviors across the most commonly used autism spectrum disorder measures
por: Uljarević, Mirko, et al.
Publicado: (2021)

A review on age‐related cancer risks in PTEN hamartoma tumor syndrome
por: Hendricks, Linda A.J., et al.
Publicado: (2020)

Detection and Yield of Colorectal Cancer Surveillance in Adults with PTEN Hamartoma Tumour Syndrome
por: Drissen, Meggie M. C. M., et al.
Publicado: (2022)

The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome
por: Hoxhaj, Alma, et al.
Publicado: (2022)

Neural transcriptome of constitutional Pten dysfunction in mice and its relevance to human idiopathic Autism Spectrum Disorder
por: Tilot, Amanda K, et al.
Publicado: (2015)

Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits
por: He, Xin, et al.
Publicado: (2015)

Gastrointestinal polyposis and PTEN mutations: an under-acknowledged diagnostic criterion
por: Heald, Brandie, et al.
Publicado: (2010)

Erratum to: Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits
por: He, Xin, et al.
Publicado: (2016)

Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation
por: Yu, Wanfeng, et al.
Publicado: (2015)

A Longitudinal Pilot Study of Behavioral Abnormalities in Children with Autism
por: Libove, Robin A., et al.
Publicado: (2017)

Beta catenin and cytokine pathway dysregulation in patients with manifestations of the "PTEN hamartoma tumor syndrome"
por: Galatola, Martina, et al.
Publicado: (2012)

OR22-02 PTEN Hamartoma Tumor Syndrome in Pediatrics: Triggers for Evaluation and the Value of Surveillance
por: Baran, Julia, et al.
Publicado: (2020)

Quantitative autism symptom patterns recapitulate differential mechanisms of genetic transmission in single and multiple incidence families
por: Frazier, Thomas W., et al.
Publicado: (2015)

Germline TTN variants are enriched in PTEN-wildtype Bannayan–Riley–Ruvalcaba syndrome
por: Yehia, Lamis, et al.
Publicado: (2017)

Validation of a computational phenotype for finding patients eligible for genetic testing for pathogenic PTEN variants across three centers
por: Kothari, Cartik, et al.
Publicado: (2022)

Relationship Between Social Motivation in Children With Autism Spectrum Disorder and Their Parents
por: Uljarević, Mirko, et al.
Publicado: (2021)

Differential expression of PTEN gene correlates with phenotypic heterogeneity in three cases of patients showing clinical manifestations of PTEN hamartoma tumour syndrome
por: Paparo, Lorella, et al.
Publicado: (2013)

PTEN interacts with RNA polymerase II to dephosphorylate polymerase II C-terminal domain
por: Abbas, Ata, et al.
Publicado: (2019)

Multifocal demyelinating motor neuropathy and hamartoma syndrome associated with a de novo PTEN mutation
por: Bansagi, Boglarka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3et2032bgt8rsrv1rb73n2nokh